Nippon India Pharma Fund vs HDFC Pharma and Healthcare Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Fund | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹828 Cr | ₹7404 Cr |
| Min Investment | ₹100 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹500 |
| Min Addl Investment | ₹100 | ₹1000 |
| Launch Date | 05 Oct 2023 | 01 Jun 2004 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | BSE Healthcare |
| Turn Over | % | 21% |
| Expense Ratio | 2.29 | 1.82 |
| Manager | Dhruv Muchhal | Sailesh Raj Bhan |
| ISIN Code | INF179KC1HL7 | INF204K01968 |
| Exits Load | Exit load of 1%, if redeemed within 30 days./365 | Exit load of 1% if redeemed within 1 month./365 |
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Month | -1.21% | -3.38% |
| 6 Month | 30.13% | 19.99% |
| 1 Year | 55.99% | 40.99% |
| 3 Year | - | 19.17% |
| 5 Year | - | 28.13% |
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 51.55% | 31.44% |
| 3 Year | - | 30.78% |
| 5 Year | - | 25.57% |
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Year | 62.28% | 17.79% |
| 3 Year | - | 20.87% |
| 5 Year | - | 20.18% |
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Standard Deviation | - | 14.36% |
| Sharp | - | 0.68% |
| Beta | - | 0.91% |
| Alpha | - | 1.57% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Name | Dhruv Muchhal | Sailesh Raj Bhan |
| Total AUM | ₹520687 Cr | ₹96086 Cr |
| Fund Manage | 40 | 5 |
| HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 1.98 | 1.66 |
| Small Cap | 33.12 | 20.97 |
| Large Cap | 32.5 | 41.85 |
| Mid Cap | 32.4 | 35.52 |
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 1.98 | 1.66 |
| Pharmaceuticals & Biotechnology | 74.71 | - |
| Healthcare Services | 22.28 | - |
| Retailing | 1.03 | - |
| Healthcare | - | 98.34 |
Top Comparisons
Invesco India - Invesco Global Equity Income Fund of Fund - Regular Plan - Growth
3Y Returns13.6%
Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth
3Y Returns6.37%
SBI Infrastructure Fund - Regular Plan - Growth
3Y Returns24.55%
DSP India T.I.G.E.R. Fund - Regular Plan - Growth
3Y Returns29.62%
ICICI Prudential Focused Equity Fund - Growth
3Y Returns18.55%
Nippon India Focused Equity Fund -Growth Plan -Growth Option
3Y Returns11.65%
DSP Gilt Fund - Regular Plan - Growth
3Y Returns6.52%
Axis Gilt Fund - Regular Plan - Growth Option
3Y Returns6.24%